Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) Cost of Revenue (2022 - 2025)

Historic Cost of Revenue for Innoviva (INVA) over the last 6 years, with Q3 2025 value amounting to $25.6 million.

  • Innoviva's Cost of Revenue rose 15668.67% to $25.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.1 million, marking a year-over-year increase of 3900.04%. This contributed to the annual value of $36.6 million for FY2024, which is 1082.36% down from last year.
  • Innoviva's Cost of Revenue amounted to $25.6 million in Q3 2025, which was up 15668.67% from $10.6 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Cost of Revenue peaked at $25.6 million during Q3 2025, and registered a low of $3.7 million during Q3 2022.
  • Moreover, its 4-year median value for Cost of Revenue was $9.5 million (2023), whereas its average is $10.6 million.
  • Per our database at Business Quant, Innoviva's Cost of Revenue skyrocketed by 17668.48% in 2023 and then tumbled by 1940.57% in 2025.
  • Quarter analysis of 4 years shows Innoviva's Cost of Revenue stood at $3.7 million in 2022, then skyrocketed by 176.68% to $10.2 million in 2023, then dropped by 1.89% to $10.0 million in 2024, then skyrocketed by 156.69% to $25.6 million in 2025.
  • Its Cost of Revenue stands at $25.6 million for Q3 2025, versus $10.6 million for Q2 2025 and $8.8 million for Q1 2025.